Phosphatidylinositol (PtdIns) 4-kinases catalyze the conversion of PtdIns to PtdIns 4-phosphate, the major precursor of phosphoinositides that regulates a vast array of cellular processes. Based on enzymatic differences, two classes of PtdIns 4-kinase have been distinguished termed Types II and III. Type III kinases, which belong to the phosphatidylinositol (PI) 3/4-kinase family, have been extensively characterized. In contrast, little is known about the Type II enzymes (PI4KIIs), which have been cloned and sequenced very recently. PI4KIIs bear essentially no sequence similarity to other protein or lipid kinases; hence, they represent a novel and distinct branch of the kinase superfamily. Here we define the minimal catalytic domain of a rat PI4KII isoform, PI4KII␣, and identify conserved amino acid residues required for catalysis. We further show that the catalytic domain by itself determines targeting of the kinase to membrane rafts. To verify that the PI4KII family extends beyond mammalian sources, we expressed and characterized Drosophila PI4KII and its catalytic domain. Depletion of PI4KII from Drosophila cells resulted in a severe reduction of PtdIns 4-kinase activity, suggesting the in vivo importance of this enzyme.Phosphoinositides (PIs), 1 especially PtdIns 4,5-biphosphate and PtdIns 3,4,5-trisphosphate, are key regulators of many cell functions (1-5). The major, so-called canonical pathway leading to the synthesis of these two PIs begins with phosphorylation of PtdIns on the D-4 hydroxyl by PtdIns 4-kinases. Two classes of PtdIns 4-kinase, Types II and III, have been identified (6). They are distinguished primarily by differences in their enzymatic properties; Type II kinases have 3-7-fold lower K m values for PtdIns and ATP than Type III kinases, they are about 20-fold more sensitive than Type III kinases to inhibition by adenosine, and they are insensitive to inhibition by wortmannin, a drug that inhibits the Type III kinases at submicromolar concentrations (for reviews, see Refs. 7 and 8). In addition, a monoclonal antibody (4C5G) raised against partially purified PI4KII from bovine brain selectively inhibits Type II kinase activities (9).In 1993 Flanagan et al. (10) reported the first sequence of a PtdIns 4-kinase, a 125-kDa enzyme purified a year earlier from Saccharomyces cerevisiae (11). The enzymatic properties of this yeast kinase, now known as Pik1p, placed it in the Type III class. Shortly thereafter, a 216-kDa Type III kinase, Stt4p, was also cloned from yeast (12). Mammalian orthologs of Stt4p and Pik1p, sometimes designated PI4KIII␣ and PI4KIII, respectively, were soon cloned and sequenced (13-18). The two forms of PI4KIII contain two regions of homology, the C-terminal catalytic domain and an internal "lipid kinase unique" domain. Homologous domains are also found in PI 3-kinases and in a group of related Ser/Thr protein kinases, including RAFT, TOR, ATM, and DNA-dependent protein kinase (19). Therefore, Type III PtdIns 4-kinase have been classified as members of the PI3/PI4-kinase fa...